Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis

Midori Sugisaki (Tokyo, Japan), Midori Sugisaki, Eri Hagiwara, Hiroyuki Ito, Norikazu Matsuo, Tomohisa Baba, Shigeru Komatsu, Takashi Ogura

Source: International Congress 2015 – Immunodepression and severe pneumonia
Session: Immunodepression and severe pneumonia
Session type: Thematic Poster Session
Number: 2652
Disease area: Interstitial lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Midori Sugisaki (Tokyo, Japan), Midori Sugisaki, Eri Hagiwara, Hiroyuki Ito, Norikazu Matsuo, Tomohisa Baba, Shigeru Komatsu, Takashi Ogura. Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis. Eur Respir J 2015; 46: Suppl. 59, 2652

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features of invasive pulmonary aspergillosis in critical ill patients with chronic respiratory disease
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a perspective study
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis
Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020
Year: 2021



Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008



Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019

Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013


Delay in diagnosis of COPD leading to poor prognosis of disease
Source: International Congress 2015 – Different data in COPD
Year: 2015


Antibiotic resistance in ambulatory patients with chronic obstructive pulmonary disease–clinical signs
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013


Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Viral infections
Year: 2013

Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010


Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Fungal VAP
Source: Eur Respir Mon 2011; 53: 122-137
Year: 2011


Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction
Source: International Congress 2014 – Comorbidities
Year: 2014


Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016


Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021


Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014